There is significant interest inBMY by institutional investors. The 73.75% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended March 2015, these large investors purchased a net $6.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 4.1 Million shares of Bristol-Myers Squibb
THE VANGUARD GROUP, INC. Bought 3.3 Million shares of Bristol-Myers Squibb
CITADEL ADVISORS LLC Bought 3.2 Million shares of Bristol-Myers Squibb